Valve Experts: Tissue Engineering Can Solve Mechanical/Tissue Dilemma
This article was originally published in The Gray Sheet
Tissue engineering may someday yield heart valve repair technologies that overcome the limitations of existing tissue and mechanical valves if a variety of technical challenges can be overcome, according to experts at a recent symposium on valve technology
You may also be interested in...
Starts & Stops: Check-Cap Starts US Trial; Venous Valve Study Begins; CorMatrix Looks At ‘Living’ Tricuspid Valve
Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by MedDeviceTracker. This edition covers trial announcements from Feb. 11 through Feb. 24, including announcements from CorMatrix Cardiovascular, Hancock Jaffe Laboratories, Toray Industries, Spectral Medical, GI Dynamics, and Check-Cap.
Market Intel: Martin Leon's TAVR Technology Tour Of The Future
Transcatheter aortic valve replacement pioneer Martin Leon discussed what is coming down the pike for technologies in the TAVR and heart valve device space at the recent Transcatheter Cardiovascular Therapeutics (TCT) conference in San Diego. Here is a run-down of what he highlighted, including AI-driven technologies that promise to improve patient access and outcomes. This is the first of a two-part series focusing on innovations in interventional cardiology.
Starts & Stops: Corlife's Decellularized Human Pulmonary Valve Shows Early Promise
Starts & Stops is a regular feature highlighting Medtech Insight editors' picks of noteworthy medtech clinical trial initiations, completions and suspensions each month. News about trials of cardiovascular devices, especially novel heart valve replacement technologies, lead this month's edition, covering mid-May through mid-June.